{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:17:04Z","timestamp":1789708624713,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Previous studies have revealed four distinct epigenetic consensus pineoblastoma (PB) subtypes. The aim of this study was to confirm and further extend their respective genetic underpinnings. Cytogenetics of 83\u00a0PB were analyzed by high-resolution genome-wide molecular inversion probe analysis and methylation profiling. Seventy-nine cases were screened for mutations by next-generation DNA panel sequencing and for 25 samples mRNA expression was analyzed using NanoString. Additionally, 24 further pineal parenchymal tumors were analyzed. Clinical data of 63 patients was available. Our cohort consisted of 48\u00a0PB-miRNA1, 19\u00a0PB-miRNA2, 8\u00a0PB-MYC\/FOXR2, and 8\u00a0PB-RB1 cases. PB-miRNA subtype tumors had characteristic alterations in microRNA-processing genes;\n                    <jats:italic>DICER1<\/jats:italic>\n                    mutations (n\u2009=\u200919\/64) and homozygous deletions of the\n                    <jats:italic>DROSHA<\/jats:italic>\n                    locus (n\u2009=\u200918\/67) were most abundant, followed by\n                    <jats:italic>DROSHA<\/jats:italic>\n                    mutations (n\u2009=\u200912\/64). Most frequent cytogenetic aberrations in PB-miRNA cases were chromosome 7 gains (n\u2009=\u200931\/67) and chromosome 14 losses (n\u2009=\u200926\/67, including 5 cases with copy-neutral LOH). The latter were significantly associated with\n                    <jats:italic>DICER1<\/jats:italic>\n                    mutations (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001).\n                    <jats:italic>OTX2<\/jats:italic>\n                    gain represented the most frequent alteration that occurred in 37\/83\u00a0PB of all subtypes. In the PB-miRNA subtypes we identified cases with polyploid cytogenetics (n\u2009=\u200916\/67). In contrast to previous publications, we did not find a difference in survival for the PB-miRNA subtypes, whereas PB-MYC\/FOXR2 and PB-RB1 in infants showed a worse outcome. Epigenetically defined PB subtypes are characterized by distinct genetic events. Frequent gains of the oncogene\n                    <jats:italic>OTX2<\/jats:italic>\n                    indicate a role in the pathogenesis of PB independent of its subtype.\n                  <\/jats:p>","DOI":"10.1186\/s40478-025-02140-7","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:03:44Z","timestamp":1764072224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recurrent genetic alterations in epigenetically defined pineoblastoma subtypes"],"prefix":"10.1186","volume":"13","author":[{"given":"Tobias","family":"Goschzik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Pfaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel E. B.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mynarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"D\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T. W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan M.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"14","key":"2140_CR1","doi-asserted-by":"publisher","DOI":"10.3171\/CASE2213","volume":"3","author":"JP Antonios","year":"2022","unstructured":"Antonios JP, Yalcin K, Darbinyan A, Koo A, Hong CS, DiLuna M, Erson-Omay Z (2022) Biallelic inactivation of PBRM1 as a molecular driver in a rare pineoblastoma case: illustrative case. J Neurosurg Case Lessons 3(14):2213. https:\/\/doi.org\/10.3171\/CASE2213","journal-title":"J Neurosurg Case Lessons"},{"issue":"7","key":"2140_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2217\/epi-2018-0195","volume":"11","author":"A Astolfi","year":"2019","unstructured":"Astolfi A, Fiore M, Melchionda F, Indio V, Bertuccio SN, Pession A (2019) Bcor involvement in cancer. Epigenomics 11(7):835\u2013855","journal-title":"Epigenomics"},{"key":"2140_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exer.2013.03.007","volume":"111","author":"F Beby","year":"2013","unstructured":"Beby F, Lamonerie T (2013) The homeobox gene Otx2 in development and disease. Exp Eye Res 111:9\u201316. https:\/\/doi.org\/10.1016\/j.exer.2013.03.007","journal-title":"Exp Eye Res"},{"issue":"50","key":"2140_CR4","doi-asserted-by":"publisher","first-page":"20007","DOI":"10.1073\/pnas.0710052104","volume":"104","author":"R Beroukhim","year":"2007","unstructured":"Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D et al (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A 104(50):20007\u201320012. https:\/\/doi.org\/10.1073\/pnas.0710052104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"2140_CR5","doi-asserted-by":"publisher","first-page":"e63604","DOI":"10.1002\/ajmg.a.63604","volume":"194","author":"C Blake","year":"2024","unstructured":"Blake C, Widmeyer K, DAquila K, Mochizuki A, Smolarek TA, Pillay-Smiley N, Kim SY (2024) 14q22.3 duplication including OTX2 in a girl with medulloblastoma: a case report with literature review. Am J Med Genet A 194(7):e63604. https:\/\/doi.org\/10.1002\/ajmg.a.63604","journal-title":"Am J Med Genet A"},{"issue":"2","key":"2140_CR6","doi-asserted-by":"publisher","first-page":"E21","DOI":"10.1002\/ijc.26474","volume":"131","author":"J Bunt","year":"2012","unstructured":"Bunt J, Hasselt NE, Zwijnenburg DA, Hamdi M, Koster J, Versteeg R, Kool M (2012) OTX2 directly activates cell cycle genes and inhibits differentiation in medulloblastoma cells. Int J Cancer 131(2):E21\u2013E32. https:\/\/doi.org\/10.1002\/ijc.26474","journal-title":"Int J Cancer"},{"issue":"10","key":"2140_CR7","doi-asserted-by":"publisher","first-page":"e26058","DOI":"10.1371\/journal.pone.0026058","volume":"6","author":"J Bunt","year":"2011","unstructured":"Bunt J, Hasselt NE, Zwijnenburg DA, Koster J, Versteeg R, Kool M (2011) Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma. PLoS ONE 6(10):e26058. https:\/\/doi.org\/10.1371\/journal.pone.0026058","journal-title":"PLoS ONE"},{"key":"2140_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DT, Sill M, Hovestadt V, Schrimpf D, Sturm D et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469","journal-title":"Nature"},{"issue":"10","key":"2140_CR9","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/S1470-2045(14)70336-5","volume":"15","author":"MC de Jong","year":"2014","unstructured":"de Jong MC, Kors WA, de Graaf P, Castelijns JA, Kivel\u00e4 T, Moll AC (2014) Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol 15(10):1157\u20131167. https:\/\/doi.org\/10.1016\/S1470-2045(14)70336-5","journal-title":"Lancet Oncol"},{"issue":"4","key":"2140_CR10","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-019-01997-y","volume":"139","author":"L de Kock","year":"2019","unstructured":"de Kock L, Priest JR, Foulkes WD, Alexandrescu S (2019) An update on the central nervous system manifestations of DICER1 syndrome. Acta Neuropathol 139(4):689\u2013701. https:\/\/doi.org\/10.1007\/s00401-019-01997-y","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2140_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00401-014-1318-7","volume":"128","author":"L de Kock","year":"2014","unstructured":"de Kock L, Sabbaghian N, Druker H, Weber E, Hamel N, Miller S et al (2014) Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol 128(4):583\u2013595. https:\/\/doi.org\/10.1007\/s00401-014-1318-7","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2140_CR12","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00401-022-02505-5","volume":"144","author":"T Goschzik","year":"2022","unstructured":"Goschzik T, Mynarek M, Doerner E, Schenk A, Spier I, Warmuth-Metz M et al (2022) Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas. Acta Neuropathol 144(6):1143\u20131156. https:\/\/doi.org\/10.1007\/s00401-022-02505-5","journal-title":"Acta Neuropathol"},{"issue":"12","key":"2140_CR13","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/S1470-2045(18)30532-1","volume":"19","author":"T Goschzik","year":"2018","unstructured":"Goschzik T, Schwalbe EC, Hicks D, Smith A, Zur Muehlen A, Figarella-Branger D et al (2018) Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT\/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial. Lancet Oncol 19(12):1602\u20131616. https:\/\/doi.org\/10.1016\/S1470-2045(18)30532-1","journal-title":"Lancet Oncol"},{"issue":"1","key":"2140_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s40478-024-01759-2","volume":"12","author":"J Hench","year":"2024","unstructured":"Hench J, Hultschig C, Brugger J, Mariani L, Guzman R, Soleman J et al (2024) EpiDiP\/NanoDiP: a versatile unsupervised machine learning edge computing platform for epigenomic tumour diagnostics. Acta Neuropathol Commun 12(1):51. https:\/\/doi.org\/10.1186\/s40478-024-01759-2","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"2140_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00401-013-1126-5","volume":"125","author":"V Hovestadt","year":"2013","unstructured":"Hovestadt V, Remke M, Kool M, Pietsch T, Northcott PA, Fischer R et al (2013) Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol 125(6):913\u2013916. https:\/\/doi.org\/10.1007\/s00401-013-1126-5","journal-title":"Acta Neuropathol"},{"key":"2140_CR16","doi-asserted-by":"publisher","first-page":"25264","DOI":"10.1038\/srep25264","volume":"6","author":"IE Kooi","year":"2016","unstructured":"Kooi IE, Mol BM, Massink MP, Ameziane N, Meijers-Heijboer H, Dommering CJ et al (2016) Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Sci Rep 6:25264","journal-title":"Sci Rep"},{"issue":"5","key":"2140_CR17","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00401-019-01990-5","volume":"137","author":"JC Lee","year":"2019","unstructured":"Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS et al (2019) Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathol 137(5):851\u2013854. https:\/\/doi.org\/10.1007\/s00401-019-01990-5","journal-title":"Acta Neuropathol"},{"key":"2140_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-019-02111-y","volume":"139","author":"BK Li","year":"2020","unstructured":"Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M et al (2020) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a rare brain tumor consortium registry study. Acta Neuropathol 139:223\u2013241. https:\/\/doi.org\/10.1007\/s00401-019-02111-y","journal-title":"Acta Neuropathol"},{"key":"2140_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-019-02106-9","volume":"139","author":"APY Liu","year":"2020","unstructured":"Liu APY, Gudenas B, Lin T, Orr BA, Klimo P Jr, Kumar R et al (2020) Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol 139:259\u2013271. https:\/\/doi.org\/10.1007\/s00401-019-02106-9","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2140_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00401-021-02284-5","volume":"141","author":"APY Liu","year":"2021","unstructured":"Liu APY, Li BK, Pfaff E, Gudenas B, Vasiljevic A, Orr BA et al (2021) Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study. Acta Neuropathol 141(5):771\u2013785. https:\/\/doi.org\/10.1007\/s00401-021-02284-5","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2140_CR21","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00401-020-02208-9","volume":"140","author":"APY Liu","year":"2020","unstructured":"Liu APY, Priesterbach-Ackley LP, Orr BA, Li BK, Gudenas B, Reddingius RE et al (2020) WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup? Acta Neuropathol 140(4):595\u2013597. https:\/\/doi.org\/10.1007\/s00401-020-02208-9","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2140_CR22","first-page":"647","volume":"7","author":"Y Lu","year":"2017","unstructured":"Lu Y, Labak CM, Jain N, Purvis IJ, Guda MR, Bach SE et al (2017) OTX2 expression contributes to proliferation and progression in Myc-amplified medulloblastoma. Am J Cancer Res 7(3):647\u2013656","journal-title":"Am J Cancer Res"},{"key":"2140_CR23","first-page":"2579","volume":"9","author":"L Maaten","year":"2008","unstructured":"Maaten L, Hinton G (2008) Visualizing data using t-SNE. J Mach Learn Res 9:2579\u20132605","journal-title":"J Mach Learn Res"},{"key":"2140_CR24","doi-asserted-by":"crossref","unstructured":"McInnes L, Healy J, Melville J (2018) Umap: uniform manifold approximation and projection for dimension reduction. arXiv:180203426:","DOI":"10.21105\/joss.00861"},{"issue":"12","key":"2140_CR25","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nrc3410","volume":"12","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho YJ et al (2012) Medulloblastomics: the end of the beginning. Nat Rev Cancer 12(12):818\u2013834","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2140_CR26","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/neuonc\/noae080","volume":"26","author":"G Nussbaumer","year":"2024","unstructured":"Nussbaumer G, Benesch M, Grabovska Y, Mackay A, Castel D, Grill J et al (2024) Gliomatosis cerebri in children: a poor prognostic phenotype of diffuse gliomas with a distinct molecular profile. Neuro Oncol 26(9):1723\u20131737","journal-title":"Neuro Oncol"},{"key":"2140_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00401-019-02101-0","volume":"139","author":"E Pfaff","year":"2020","unstructured":"Pfaff E, Aichm\u00fcller C, Sill M, Stichel D, Snuderl M, Karajannis MA, Schuhmann MU, Schittenhelm J, Hasselblatt M, Thomas C et al (2020) Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations. Acta Neuropathol 139:243\u2013257. https:\/\/doi.org\/10.1007\/s00401-019-02101-0","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2140_CR28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1471-4159.2006.03773.x","volume":"97","author":"MF Rath","year":"2006","unstructured":"Rath MF, Mu\u00f1oz E, Gangul S, Morin F, Shi Q, Klein DC, M\u00f8ller M (2006) Expression of the Otx2 homeobox gene in the developing mammalian brain: embryonic and adult expression in the pineal gland. J Neurochem 97(2):556\u2013566. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03773.x","journal-title":"J Neurochem"},{"key":"2140_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/jmedgenet-2012-100898","volume":"49","author":"N Sabbaghian","year":"2012","unstructured":"Sabbaghian N, Hamel N, Srivastava A, Albrecht S, Priest JR, Foulkes WD (2012) Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma. J Med Genet 49:417\u2013419","journal-title":"J Med Genet"},{"key":"2140_CR30","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1038\/s41467-018-05029-3","volume":"9","author":"M Snuderl","year":"2018","unstructured":"Snuderl M, Kannan K, Pfaff E, Wang S, Stafford JM, Serrano J, Heguy A, Ray K, Faustin A, Aminova O et al (2018) Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma. Nat Commun 9:2868. https:\/\/doi.org\/10.1038\/s41467-018-05029-3","journal-title":"Nat Commun"},{"issue":"2","key":"2140_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5114\/fn.2023.129377","volume":"61","author":"J Trubicka","year":"2023","unstructured":"Trubicka J, \u0141astowska M, Karkuci\u0144ska-Wi\u0119ckowska A, Niemira M, Ejmont M, Sowi\u0144ska A et al (2023) BCOR expression in paediatric pineoblastoma. Folia Neuropathol 61(2):121\u2013128. https:\/\/doi.org\/10.5114\/fn.2023.129377","journal-title":"Folia Neuropathol"},{"issue":"7\u20138","key":"2140_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cancergen.2012.06.005","volume":"205","author":"Y Wang","year":"2012","unstructured":"Wang Y, Cottman M, Schiffman JD (2012) Molecular inversion probes: a novel microarray technology and its application in cancer research. Cancer Genet 205(7\u20138):341\u2013355. https:\/\/doi.org\/10.1016\/j.cancergen.2012.06.005","journal-title":"Cancer Genet"},{"key":"2140_CR33","unstructured":"WHO Classification of Tumours Editorial Board (2021) WHO classification of tumours of the central nervous system (5th ed). International Agency for Research on Cancer (IARC) Press, Lyon"},{"issue":"5","key":"2140_CR34","doi-asserted-by":"publisher","first-page":"e96788","DOI":"10.1371\/journal.pone.0096788","volume":"9","author":"D Zielinski","year":"2014","unstructured":"Zielinski D, Markus B, Sheikh M, Gymrek M, Chu C, Zaks M et al (2014) Otx2 duplication is implicated in hemifacial microsomia. PLoS ONE 9(5):e96788. https:\/\/doi.org\/10.1371\/journal.pone.0096788","journal-title":"PLoS ONE"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02140-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02140-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02140-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:03:47Z","timestamp":1764072227000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02140-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2140"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02140-7","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent had been given by the patients or their legal representatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"241"}}